{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:26:26Z","timestamp":1786119986976,"version":"build-2736575974"},"reference-count":79,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1111\/j.1524-4725.2011.02087.x","type":"journal-article","created":{"date-parts":[[2011,7,21]],"date-time":"2011-07-21T12:31:48Z","timestamp":1311251508000},"page":"1553-1565","source":"Crossref","is-referenced-by-count":54,"title":["Handling Botulinum Toxins"],"prefix":"10.1097","volume":"37","author":[{"given":"Ada R.","family":"Trindade De Almeida","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leticia Cardoso","family":"Secco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alastair","family":"Carruthers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-1-20210206","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3928\/0191-3913-19800101-06","article-title":"Botulinum toxin injection into extraocular muscles as an alternative to strabismus surgery.","volume":"17","author":"Scott","year":"1980","journal-title":"J Pediatr Ophthalmol Strabismus"},{"key":"R2-1-20210206","first-page":"1","article-title":"Botulinum toxin products overview.","volume":"13","author":"Carruthers","year":"2008","journal-title":"Skin Therapy Lett"},{"key":"R3-1-20210206","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/01.iio.0000167167.10402.74","article-title":"Pharmacology and immunology of botulinum neurotoxins.","volume":"45","author":"Aoki","year":"2005","journal-title":"Int Ophthalmol Clin"},{"key":"R4-1-20210206","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1007\/s00266-006-0161-1","article-title":"Reconstituted botulinum type A neurotoxin: clinical efficacy after long-term freezing before use.","volume":"31","author":"Parsa","year":"2007","journal-title":"Aesth Plast Surg"},{"key":"R5-1-20210206","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1504\/TBJ.2008.018951","article-title":"How do the botulinum neurotoxins block neurotransmitter release: from botulism to the molecular mechanism of action.","volume":"1","author":"Poulain","year":"2008","journal-title":"Botulinum J"},{"key":"R6-1-20210206","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1128\/IAI.66.6.2420-2425.1998","article-title":"Biophysical characterization of the stability of the 150kilodalton botulinum toxin, the nontoxic component, and the 900kilodalton botulinum toxin complex species.","volume":"66","author":"Chen","year":"1998","journal-title":"Infect Immun"},{"key":"R7-1-20210206","first-page":"239","article-title":"Hemagglutinin binding mediated protection of botulinum neurotoxin from proteolysis.","volume":"7","author":"Sharma","year":"1998","journal-title":"J Nat Toxins"},{"key":"R8-1-20210206","first-page":"1065","article-title":"Current and future botulinum neurotoxin type A preparations in aesthetics: a literature review.","volume":"9","author":"Sattler","year":"2010","journal-title":"J Drugs Dermatol"},{"key":"R9-1-20210206","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1111\/j.1471-4159.2009.06093.x","article-title":"Cell entry strategy of clostridial neurotoxins.","volume":"109","author":"Binz","year":"2009","journal-title":"J Neurochem"},{"key":"R10-1-20210206","doi-asserted-by":"crossref","first-page":"9621","DOI":"10.1074\/jbc.M611211200","article-title":"Mechanism of substrate recongnition by botulinum neurotoxin serotype A.","volume":"282","author":"Chen","year":"2007","journal-title":"J Biol Chem"},{"key":"R11-1-20210206","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.clindermatol.2003.11.009","article-title":"Commercial preparations and handling of botulinum toxin type A and type B.","volume":"21","author":"Parrish","year":"2003","journal-title":"Clin Dermatol"},{"key":"R12-1-20210206","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1111\/j.1524-4725.1998.tb04094.x","article-title":"Dilution and storage of botulinum toxin.","volume":"24","author":"Klein","year":"1998","journal-title":"Dermatol Surg"},{"key":"R13-1-20210206","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2147\/CIA.S9338","article-title":"Treating glabellar lines with botulinum toxin type Ahemagglutinin complex: a review of the science, the clinical data, and patient satisfaction.","volume":"5","author":"De Boulle","year":"2010","journal-title":"Clin Interv Aging"},{"key":"R21-1-20210206","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1046\/j.1524-4725.2003.29125.x","article-title":"Foam during reconstitution does not affect the potency of Botulinum toxin A.","volume":"29","author":"Trindade de Almeida","year":"2003","journal-title":"Dermatol Surg"},{"key":"R23-1-20210206","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1001\/archderm.138.4.510","article-title":"Pain associated with injection of botulinum toxin A exotoxin reconstituted using isotonic sodium chloride with and without preservative: a double blind, randomized controlled trial.","volume":"138","author":"Alam","year":"2002","journal-title":"Arch Dermatol"},{"key":"R24-1-20210206","first-page":"533","article-title":"Diffusion and Shortterm efficacy of Botulinum toxin A after addition of hyaluronidase and its possible application for the treatment of axillary hyperhidrosis.","volume":"29","author":"Goodman","year":"2003","journal-title":"Dermatol Surg"},{"key":"R25-1-20210206","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/S0025-6196(11)64616-8","article-title":"Addition of an anaesthetic agent to enhance the predictability of the effects of botulinum toxin type A injections: a randomized controlled study.","volume":"75","author":"Gassner","year":"2000","journal-title":"Mayo Clin Proc"},{"key":"R26-1-20210206","first-page":"523","article-title":"Multicenter, double blind study of the efficacy of injections with botulinum toxin type A reconstituted up to six consecutive weeks before application.","volume":"29","author":"Hexsel","year":"2003","journal-title":"Dermatol Surg"},{"key":"R27-1-20210206","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1177\/019459989310800205","article-title":"Cristalline preparation of Botulinum toxin type A (Botox): degradation in potency with storage.","volume":"108","author":"Gartlan","year":"1993","journal-title":"Otolaryngol Head Neck Surg"},{"key":"R28-1-20210206","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1097\/01.PRS.0000061003.68203.56","article-title":"Efficacy of reconstituted and stored Botulinum toxin Type A: an electrophysiologic study in the auricular muscle of the rabbit.","volume":"111","author":"Jabor","year":"2003","journal-title":"Plast Reconstr Surg"},{"key":"R29-1-20210206","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1177\/019459989310900537","article-title":"Potency of frozenthawned botulinum toxin type A in the treatment of torsion dystonia.","volume":"109","author":"Greene","year":"1993","journal-title":"Otolaryngol Head Neck Surg"},{"key":"R30-1-20210206","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1212\/WNL.48.1.249","article-title":"Reconstituted botulinum toxin type A does not loose potency in humans if refrozen or refrigerated for 2 weeks before use.","volume":"48","author":"Sloop","year":"1997","journal-title":"Neurol"},{"key":"R31-1-20210206","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.otohns.2006.04.001","article-title":"Frozen versus fresh reconstituted botox for laryngeal dystonia.","volume":"135","author":"Thomas","year":"2006","journal-title":"Otolaryngol Head Neck Surg"},{"key":"R32-1-20210206","first-page":"S7","article-title":"Expanding the use of neurotoxins in facial aesthetics: a consensus panels assessment and recommendations.","volume":"9","author":"Kane","year":"2010","journal-title":"J Drugs Dermatol"},{"key":"R33-1-20210206","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1097\/01.IOP.0000129012.09632.49","article-title":"Increased patient comfort utilizing botulinum toxin type A reconstituted with preserved versus nonpreserved saline.","volume":"20","author":"Kwiat","year":"2004","journal-title":"Ophthalm Plastic Reconstruct Surg"},{"key":"R34-1-20210206","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s00266-004-0062-0","article-title":"Evaluating effects of preservativecontaining saline solution on pain perception during botulinum toxin type A injections at different locations: a prospective, single-blinded, randomized controlled trial.","volume":"29","author":"Sarifakioglu","year":"2005","journal-title":"Aesth Plast Surg"},{"key":"R35-1-20210206","first-page":"764","article-title":"Simultaneous injection of lidocaine improves predictability of effect of botulinum toxin.","volume":"88","author":"Haubner","year":"2009","journal-title":"Laryngorrhinootologie"},{"key":"R36-1-20210206","first-page":"1135","article-title":"Hyaluronic acid filler and botulinum neurotoxin delivered simultaneously in the same syringe for effective and convenient combination aesthetic rejuvenation therapy.","volume":"9","author":"Kenner","year":"2010","journal-title":"J Drug Dermatol"},{"key":"R37-1-20210206","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1111\/j.1365-2133.2007.07760.x","article-title":"Treatment of axillary hyperhidrosis with botulinum toxin type a reconstituted in lidocaine or in normal saline: a randomized, side-by-side, double-blind study.","volume":"156","author":"VadoudSeyedi","year":"2007","journal-title":"Br J Dermatol"},{"key":"R38-1-20210206","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1520\/JFS2004196","article-title":"Fatal case of Botoxrelated anaphylaxis?","volume":"50","author":"Li","year":"2005","journal-title":"J Forensic Sci"},{"key":"R39-1-20210206","first-page":"461","article-title":"A pilot study on the effect of epinephrine on botulinum toxin treatment for periorbital rhytides.","volume":"33","author":"Hantash","year":"2007","journal-title":"Dermatol Surg"},{"key":"R40-1-20210206","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1080\/14764170310021841","article-title":"Botulinum toxin dilution: our technique.","volume":"5","author":"Redaelli","year":"2003","journal-title":"J Cosmetic Laser Ther"},{"key":"R41-1-20210206","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s002660010100","article-title":"Botulinum toxin A and facial lines: the variable concentration.","volume":"25","author":"Le Louarn","year":"2001","journal-title":"Aesthet Plast Surg"},{"key":"R42-1-20210206","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1097\/SAP.0b013e318045a083","article-title":"Bupivacaineinduced myotoxicity and its effect on botulinum toxin paresis.","volume":"60","author":"Yen","year":"2008","journal-title":"Ann Plast Surg"},{"key":"R44-1-20210206","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1006\/exnr.2000.7583","article-title":"Botulinum A toxin: dysport improvement of biological availability.","volume":"168","author":"Bigalke","year":"2001","journal-title":"Exp Neurol"},{"key":"R45-1-20210206","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s00702-009-0200-6","article-title":"Experience with longterm treatment with albuminsupplemented botulinum toxin type A.","volume":"116","author":"Mohammadi","year":"2009","journal-title":"J Neural Transm"},{"key":"R46-1-20210206","doi-asserted-by":"crossref","first-page":"3302","DOI":"10.1002\/jps.21676","article-title":"Extreme sensitivity of botulinum neurotoxin domains towards mild agitation.","volume":"98","author":"Toth","year":"2009","journal-title":"J Pharm Sci"},{"key":"R47-1-20210206","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1111\/j.1524-4725.2010.01702.x","article-title":"Botulinum toxin A: is it really a fragile molecule?","volume":"36","author":"Shome","year":"2010","journal-title":"Dermatol Surg"},{"key":"R48-1-20210206","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1097\/00042728-200305000-00016","article-title":"Foam during reconstitution does not affect the potency of botuinum toxin type A.","volume":"29","author":"Almeida","year":"2003","journal-title":"Dermatol Surg"},{"key":"R49-1-20210206","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/IOP.0b013e3181607475","article-title":"Botox: shaken, not stirred.","volume":"24","author":"Kazim","year":"2008","journal-title":"Ophtal Plast Reconstr Surg"},{"key":"R50-1-20210206","first-page":"220","article-title":"Potential foreign body emboli associated with botulinum toxin A injections.","volume":"6","author":"Beer","year":"2007","journal-title":"J Drugs Dermatol"},{"key":"R51-1-20210206","first-page":"S22","article-title":"The biochemistry of botulinum toxin type B.","volume":"55","author":"Setler","year":"2000","journal-title":"Neurology"},{"key":"R52-1-20210206","first-page":"523","article-title":"Multicenter, doubleblind study of the efficacy of injections with botulinum toxin type A reconstituted up to six consecutive weeks before application.","volume":"29","author":"Hexsel","year":"2003","journal-title":"Dermatol Surg"},{"key":"R53-1-20210206","first-page":"1328","article-title":"Clinical efficacy of botulinum toxin type A reconstituted and refrigerated 1 week before its application in external canthus dynamic lines.","volume":"33","author":"Lizarralde","year":"2007","journal-title":"Dermatol Surg"},{"key":"R54-1-20210206","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/IOP.0b013e31815793b7","article-title":"Efficacy of fresh versus refrigerated botulinum toxin in the treatment of lateral periorbital rhytids.","volume":"23","author":"Hui","year":"2007","journal-title":"Ophtalm Plastic Reconstruct Surg"},{"key":"R55-1-20210206","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1111\/j.1524-4725.2009.01158.x","article-title":"Blind multicenter study of the efficacy and safety of injections of a commercial preparation of botulinum toxin type A reconstituted up to 15 days before injection.","volume":"35","author":"Hexsel","year":"2009","journal-title":"Dermatol Surg"},{"key":"R56-1-20210206","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1007\/s00266-006-0193-6","article-title":"Discussion on reconstituted botulinum type A neurotoxin: clinical efficacy after long-term freezing before use.","volume":"31","author":"Kane","year":"2007","journal-title":"Aesth Plast Surg"},{"key":"R57-1-20210206","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1097\/SAP.0b013e31802e0912","article-title":"Effect of fresh and stored botulinum toxin A on muscle and nerve ultrastructure.","volume":"59","author":"Elmas","year":"2007","journal-title":"Ann Plast Surg"},{"key":"R58-1-20210206","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1001\/archfaci.10.4.273","article-title":"Questionning the need to use Botox within 4 hours of reconstitution: a study of fresh vs 2weekold Botox.","volume":"10","author":"Yang","year":"2008","journal-title":"Arch Facial Plast Surg"},{"key":"R59-1-20210206","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.jaad.2006.01.019","article-title":"Sterility assessment of multiple use botulinum A exotoxin vials: a prospective simulation.","volume":"55","author":"Alam","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"R60-1-20210206","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1038\/sj.eye.6702465","article-title":"Microbial growth in vials of Botulinum toxin following use in clinic.","volume":"21","author":"Menon","year":"2007","journal-title":"Eye"},{"key":"R61-1-20210206","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.clindermatol.2003.12.033","article-title":"The cosmetic use of botulinum toxin type B in the upper face.","volume":"22","author":"Sadick","year":"2004","journal-title":"Clin Dermatol"},{"key":"R62-1-20210206","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.clindermatol.2003.12.027","article-title":"Botulinum toxin type B (Myobloc): phamacology and biochemistry.","volume":"22","author":"Callaway","year":"2004","journal-title":"Clin Dermatol"},{"key":"R63-1-20210206","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.1097\/01.PHM.0000141128.62598.81","article-title":"Botulinum toxin: dosing and dilution.","volume":"83","author":"Francisco","year":"2004","journal-title":"Am J Phys Med Rehabil"},{"key":"R65-1-20210206","doi-asserted-by":"crossref","first-page":"271","DOI":"10.2174\/157488606777934431","article-title":"The possible adverse effects of intramuscular botulinum toxin injections and their management.","volume":"1","author":"Bakheit","year":"2006","journal-title":"Curr Drug Safety"},{"key":"R66-1-20210206","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.det.2009.08.001","article-title":"Botulinum toxin in facial rejuvenation: an update.","volume":"27","author":"Carruthers","year":"2009","journal-title":"Dermatol Clin"},{"key":"R67-1-20210206","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2165\/00128071-200506030-00001","article-title":"Managing adverse events associated with botulinum toxin type A.","volume":"6","author":"Wollina","year":"2005","journal-title":"Am J Clin Dermatol"},{"key":"R68-1-20210206","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0733-8635(03)00018-4","article-title":"Dilution, storage, and electromyographic guidance in the use of botulinum toxins.","volume":"22","author":"Mantel","year":"2004","journal-title":"Dermatol Clin"},{"key":"R69-1-20210206","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1111\/j.1468-3083.2010.03728.x","article-title":"International consensus recommendations on the aesthetic usage of botulinum toxin type A (Speywood Unit) - part I: upper facial wrinkles.","volume":"24","author":"Asher","year":"2010","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R70-1-20210206","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1524-4725.1996.tb00569.x","article-title":", Fulton J. Cosmetic denervation of muscles of facial expression with botulinum toxin; a dose response study.","volume":"22","author":"Garcia","year":"1996","journal-title":"Dermatol Surg"},{"key":"R71-1-20210206","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1111\/j.1524-4725.1998.tb04101.x","article-title":"The Newport Beach experience.","volume":"24","author":"Fulton","year":"1998","journal-title":"Dermatol Surg"},{"key":"R72-1-20210206","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1111\/j.1524-4725.1998.tb04095.x","article-title":"Botulinum A toxin for glabellar wrinkles. Dose and response.","volume":"24","author":"Hankins","year":"1998","journal-title":"Dermatol Surg"},{"key":"R73-1-20210206","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1001\/archderm.140.11.1351","article-title":"Effect of volume and concentration on the diffusion of botulinum exotoxin A.","volume":"140","author":"Hsu","year":"2004","journal-title":"Arch Dermatol"},{"key":"R74-1-20210206","doi-asserted-by":"crossref","first-page":"S97","DOI":"10.1111\/j.1524-4725.2006.32339.x","article-title":"Dilution volume of botulinum toxin type A for the treatment of glabellar rhytides: does it matter?","volume":"33","author":"Carruthers","year":"2007","journal-title":"Dermatol Surg"},{"key":"R75-1-20210206","first-page":"567","article-title":"A randomized, evaluatorblinded, twocenter study of the safety and effect of volume on the diffusion and efficacy of botulinum toxin type A in the treatment of lateral orbital rhytides.","volume":"33","author":"Carruthers","year":"2007","journal-title":"Dermatol Surg"},{"key":"R76-1-20210206","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1007\/s00105-009-1840-z","article-title":"Does dilution have an impact on cosmetic results with BoNTA? Complexproteinfree BoNTA for treatment of glabella lines.","volume":"60","author":"Prager","year":"2009","journal-title":"Hautarzt"},{"key":"R77-1-20210206","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/IOP.0b013e31819946c4","article-title":"High versus low concentration botulinum toxin A for benign essential blepharospasm: does dilution make a difference?","volume":"25","author":"Boyle","year":"2009","journal-title":"Ophthal Plast Reconstr Surg"},{"key":"R78-1-20210206","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1002\/mus.880160913","article-title":"Quantifying how location and dose of botulinum toxin injections affect muscle paralysis.","volume":"16","author":"Shaari","year":"1993","journal-title":"Muscle Nerve"},{"key":"R79-1-20210206","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1017\/S0012162203000380","article-title":"Effect of muscle activity and botulinum toxin dilution volume on muscle paralysis.","volume":"45","author":"Kim","year":"2003","journal-title":"Dev Med Child Neurol"},{"key":"R80-1-20210206","doi-asserted-by":"crossref","first-page":"67","DOI":"10.18325\/jkmr.2018.28.3.67","article-title":"Effects of dilution volume of botulinum toxin A.","volume":"28","author":"Shin","year":"2000","journal-title":"J Korean Acad Phys Med Rehab"},{"key":"R82-1-20210206","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/00002060-200205000-00007","article-title":"Botulinum toxin in upper limb spasticity after acquired brain injury: a randomized trial comparing dilution techniques.","volume":"81","author":"Francisco","year":"2002","journal-title":"Am J Phys Med Rehabil"},{"key":"R83-1-20210206","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.apmr.2008.04.030","article-title":"Botulinum toxin dilution and endplate targeting in spasticity: a double-blind controlled study.","volume":"90","author":"Gracies","year":"2009","journal-title":"Arch Phys Med Rehabil"},{"key":"R84-1-20210206","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1097\/01.PHM.0000137314.38806.95","article-title":"Botulinum toxin for lower limb spasticity in children with cerebral palsy: a single- blinded trial comparing dilution techniques.","volume":"83","author":"Lee","year":"2004","journal-title":"Am J Phys Med Rehabil"},{"key":"R85-1-20210206","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1177\/0269215508097861","article-title":"Botulinum toxin (Dysport) treatment of the spastic gastrocnemius muscle in children with cerebral palsy: a randomized trial comparing two injection volumes.","volume":"23","author":"Hu","year":"2009","journal-title":"Clin Rehabil"},{"key":"R86-1-20210206","doi-asserted-by":"crossref","first-page":"87","DOI":"10.2165\/00128071-200910020-00002","article-title":"Botulinum toxin for hyperhidrosis: a review.","volume":"10","author":"Grunfeld","year":"2009","journal-title":"Am J Clin Dermatol"},{"issue":"suppl 5","key":"R88-1-20210206","first-page":"29","article-title":"Facial hyperhidrosis: best practice recommendations and special considerations.","volume":"79","author":"Glaser","year":"2007","journal-title":"Cutis"},{"key":"R89-1-20210206","doi-asserted-by":"crossref","first-page":"S44","DOI":"10.1111\/j.1524-4725.2006.32331.x","article-title":"A doubleblind, randomized, comparative study of two type A botulinum toxins in the treatment of primary axillary hyperhidrosis.","volume":"33","author":"Talarico Filho","year":"2007","journal-title":"Dermatol Surg"},{"key":"R90-1-20210206","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s00702-010-0372-0","article-title":"Comparing botox and xeomin for axillar hyperhidrosis.","volume":"117","author":"Dressler","year":"2010","journal-title":"J Neural Transm"},{"key":"R92-1-20210206","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1001\/archdermatol.2009.128","article-title":"Increasing the field effects of similar doses of Clostridium botulinum type A toxinhemagglutinin complex in the treatment of compensatory hyperhidrosis.","volume":"145","author":"Hexsel","year":"2009","journal-title":"Arch Dermatol"}],"container-title":["Dermatologic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00042728-201111000-00001","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T19:36:39Z","timestamp":1786044999000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00042728-201111000-00001"}},"subtitle":["An Updated Literature Review"],"short-title":[],"issued":{"date-parts":[[2011,11]]},"references-count":79,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1524-4725.2011.02087.x","relation":{},"ISSN":["1076-0512"],"issn-type":[{"value":"1076-0512","type":"print"}],"subject":[],"published":{"date-parts":[[2011,11]]}}}